Effect of glycosaminoglycan polysulfate on chondromalacia patellae: A placebo-controlled 1-year study
DOI:
https://doi.org/10.3109/17453679008993559Abstract
The effect of glycosaminoglycan polysulfate (GAGPS) on damaged patellar cartilage and clinical symptoms of chondromalacia was studied on 31 patients in a placebo-controlled double-blind trial. The clinical diagnosis was confirmed by arthroscopy. The treatment consisted of 12 intramuscular injections of either GAGPS or placebo, and the patients were followed for 1 year. In 26 patients, rearthroscopy was performed at the 1-year follow-up. Comparison of the two arthroscopies showed improvement in 8/13 patients in the GAGPS group compared with 3/13 in the placebo group. The clinical parameters correlated well with the results of the arthroscopies. The results sup-port the use of GAGPS for chondromalacia patellae.Downloads
Download data is not yet available.
Downloads
Published
1990-01-01
How to Cite
Raatikainen, T., Väänänen, K., & Tamelander, G. (1990). Effect of glycosaminoglycan polysulfate on chondromalacia patellae: A placebo-controlled 1-year study. Acta Orthopaedica, 61(5), 443–448. https://doi.org/10.3109/17453679008993559
Issue
Section
Articles
License
Acta Orthopaedica (Scandinavica) content is available freely online as from volume 1, 1930. The journal owner owns the copyright for all material published until volume 80, 2009. As of June 2009, the journal has however been published fully Open Access, meaning the authors retain copyright to their work. As of June 2009, articles have been published under CC-BY-NC or CC-BY licenses, unless otherwise specified.
